All of us produce GLP-1, which is an incretin hormone that gets released into our bloodstream when we eat
Yes, injecting GLP-1 medications above the belly button is generally acceptable and falls within FDA-approved guidelines for abdominal injection sites
The company discontinued its 3-milliliter vials of Humalog, which is mainly used by hospitals, to free up capacity for the 10-milliliter vials, according to the company's response letter to lawmakers
Key Takeaways GLP-1 medications can make staying hydrated more important by affecting appetite and, for some people, causing temporary gastrointestinal side effects
Amazing results Retatrutide has been a game changer for my research
A review of the relevant literature and the National Institute of Health clinical trial registry did not yield evidence that such a study has been published or is currently underway